Clinical Trial Update: Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and efficacy of Bexagliflozin in type 2 diabetes patients with moderate renal impairment has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bexagliflozin (null)

Snippet

Sponsor: Theracos | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-04-27